A Study (Study 1) to Evaluate the Safety and Efficacy of FMX103 1.5% Topical Minocycline Foam in the Treatment of Facial Papulopustular Rosacea

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
The primary objectives of this study are to determine the efficacy and safety of FMX103 1.5% minocycline foam applied topically once daily for 12 weeks in the treatment of rosacea.
Epistemonikos ID: 7cf2bc08b134b6c1cac6618d77f71ef55d169b4a
First added on: May 20, 2024